Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  03/24/2010
 
Trade Name:  Viread
 
Generic Name or Proper Name (*):  tenofovir disoproxil fumarate
 
Indications Studied:  Treatment of HIV infection in combination with other antiretroviral agents
 
Label Changes Summary:  * Expanded indication from adults to pediatric patients 12- <18 years * Safety and effectiveness in patients < 12 years have not been established * In a clinical study of HIV-1 infected adolescents bone effects were similar to adults * The adverse reactions in trial in adolescents were consistent with those observed in clinical trials in adults * Information on dosing in adolescents weighing e35 kg, adverse reactions, and PK parameters
 
Product Labeling:  Labeling  Opens a new window
 
BPCA(B) and PREA(P):  B, P
 
Sponsor:  Gilead
 
NNPS:  FALSE
 
Therapeutic Category:  Antiviral
 
-
-